These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6684077)

  • 1. In vivo studies on the antitumor effect of cis-dichlorodiammineplatinum(II) against transplantable ovarian adenocarcinoma cells of the rat.
    Sekiya S; Iwasawa H; Takamizawa H
    Gynecol Oncol; 1983 Aug; 16(1):85-94. PubMed ID: 6684077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor effect of cis-diamminedichloroplatinum (II) against transplantable ovarian adenocarcinoma cells of the rat].
    Iwasawa H; Sekiya S; Takamizawa H
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1785-90. PubMed ID: 6892193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of resistance to cis-diamminedichloroplatinum (II) in a rat ovarian carcinoma cell line.
    Sekiya S; Oosaki T; Andoh S; Suzuki N; Akaboshi M; Takamizawa H
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):429-37. PubMed ID: 2702997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The isolation and characterization of cisplatin-resistant rat ovarian cancer cells.
    Sekiya S; Oosaki T; Andoh S; Suzuki N; Nagao K; Takamizawa H
    Eur J Cancer Clin Oncol; 1988 May; 24(5):851-9. PubMed ID: 3169090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the intraperitoneal and intravenous routes of cisplatin administration in an advanced ovarian cancer model of the rat.
    Sekiya S; Iwasawa H; Takamizawa H
    Am J Obstet Gynecol; 1985 Sep; 153(1):106-11. PubMed ID: 4041136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro studies on the antitumor effect of cis-diamminedichloroplatinum II (cisplatin) against ovarian adenocarcinoma cell line of the rat].
    Sekiya S; Iwasawa H; Takamizawa H; Sugita M; Tenjin Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1487-90. PubMed ID: 6890087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cis-Dichlorodiammineplatinum(II) as third-line chemotherapy in advanced ovarian adenocarcinoma.
    Piver MS; Barlow JJ; Lele SB; Higby DJ
    Cancer Treat Rep; 1978 Apr; 62(4):559-60. PubMed ID: 350393
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy.
    Bruckner HW; Cohen CJ; Wallach RC; Kabakow B; Deppe G; Greenspan EM; Gusberg SB; Holland JF
    Cancer Treat Rep; 1978 Apr; 62(4):555-8. PubMed ID: 350392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor action of cis-dichlorodiammineplatinum(II) and the effectiveness of a combination with sarcolysine].
    Presnov MA; Konovalova AL; Romanova LF; Sof'ina ZP; Stetsenko AI
    Vopr Onkol; 1978; 24(4):53-60. PubMed ID: 654174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.
    Wiltshaw E; Kroner T
    Cancer Treat Rep; 1976 Jan; 60(1):55-60. PubMed ID: 1000519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cis-dichlorodiammineplatinum(II) on cloned ovarian adenocarcinoma cells of the rat in vitro.
    Sekiya S; Iwasawa H; Yamauchi K; Kubota K; Takamizawa H
    Gynecol Oncol; 1981 Aug; 12(1):14-22. PubMed ID: 7196860
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of transplant generations of primary rat adenocarcinoma and some chemotherapeutic observations.
    Sugiyama T; Nishida T; Nakanami M; Ushijima K; Shibue K; Katabuchi H; Yakushiji M; Kato T
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):681-6. PubMed ID: 3108423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiences with cis-dichlorodiaminoplatinum (II) in the treatment of advanced solid tumors].
    Francesconi M; Breyer S; Mörz R; Rainer H; Moser K
    Acta Med Austriaca Suppl; 1979; 6():334-7. PubMed ID: 299224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group.
    Thigpen T; Shingleton H; Homesley H; LaGasse L; Blessing J
    Cancer Treat Rep; 1979; 63(9-10):1549-55. PubMed ID: 498154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.
    Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM
    Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of transplantable mouse tumors with cis-dichlorodiammineplatinum(II) alone and in combination with sarcolysin.
    Presnov MA; Konovalova AL; Romanova LF; Sofina ZP; Stetsenko AI
    Cancer Treat Rep; 1978 May; 62(5):705-12. PubMed ID: 657156
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of cancer chemotherapy using rat ovarian cancer induced by DMBA--observation of histologic effects by light and transmission electron microscopy, and changes in vascular system after cis-DDP treatment].
    Oda T
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):315-20. PubMed ID: 6403635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
    Britell JC; Eagan RT; Ingle JN; Creagen ET; Rubin J; Frytak S
    Cancer Treat Rep; 1978 Aug; 62(8):1207-10. PubMed ID: 688256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndrome of inappropriate antidiuretic hormone secretion during cis-dichlorodiammineplatinum therapy in a patient with an ovarian carcinoma.
    Porter AT
    Gynecol Oncol; 1985 May; 21(1):103-5. PubMed ID: 4039285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antineoplastic effects of cisplatin by calmodulin antagonists in nude mice bearing human ovarian carcinoma.
    Kikuchi Y; Oomori K; Kizawa I; Hirata J; Kita T; Miyauchi M; Kato K
    Cancer Res; 1987 Dec; 47(24 Pt 1):6459-61. PubMed ID: 3677086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.